Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yamano

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1994
[Mucin-producing tumor of the pancreas: surgery or follow-up?]T Obara, H Maguchi, Y Saitoh, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 1, 1992
[Usefulness of selective endoscopic retrograde pancreatography (selective ERP) and endoscopic pancreatic biopsy (EPB) in the diagnosis of mucin-producing tumor of the pancreas]H Maguchi, T Obara, Y Koike, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized ratsK Miyata, T Kamato, M Yamano, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissueK Miyata, T Kamato, A Nishida, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 1, 1995
[Evaluation of early colorectal cancer with submucosal invasion based on histological architecture]J Watari, Y Orii, Y Saitoh, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Nature Chemistry|August 1, 2018
Diels-Alder cycloadditions of strained azacyclic allenesJoyann S Barber, Michael M Yamano, Melissa Ramirez, et al.
Nature|August 27, 2020
Intercepting fleeting cyclic allenes with asymmetric nickel catalysisMichael M Yamano, Andrew V Kelleghan, Qianzhen Shao, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1994
[Mucin-producing tumor of the pancreas: surgery or follow-up?]T Obara, H Maguchi, Y Saitoh, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 1, 1992
[Usefulness of selective endoscopic retrograde pancreatography (selective ERP) and endoscopic pancreatic biopsy (EPB) in the diagnosis of mucin-producing tumor of the pancreas]H Maguchi, T Obara, Y Koike, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized ratsK Miyata, T Kamato, M Yamano, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissueK Miyata, T Kamato, A Nishida, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 1, 1995
[Evaluation of early colorectal cancer with submucosal invasion based on histological architecture]J Watari, Y Orii, Y Saitoh, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Nature Chemistry|August 1, 2018
Diels-Alder cycloadditions of strained azacyclic allenesJoyann S Barber, Michael M Yamano, Melissa Ramirez, et al.
Nature|August 27, 2020
Intercepting fleeting cyclic allenes with asymmetric nickel catalysisMichael M Yamano, Andrew V Kelleghan, Qianzhen Shao, et al.
Pageof 11